Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Einarson

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Clinical Therapeutics|February 13, 2003
An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based studyThomas R Einarson, Colleen J Metge, Michael Iskedjian, et al.
Pharmacoeconomics|October 27, 2007
The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analysesMárcio Machado, Michael Iskedjian, Inés A Ruiz, et al.
Journal of Environmental and Public Health|December 17, 2011
Objective assessment of an ionic footbath (IonCleanse): testing its ability to remove potentially toxic elements from the bodyDeborah A Kennedy, Kieran Cooley, Thomas R Einarson, et al.
The American Journal of Gastroenterology|June 4, 2009
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysisSimerpal K Gill, Lisa O'Brien, Thomas R Einarson, et al.
Current Medical Research and Opinion|November 8, 2016
Systematic literature review of the health economic implications of early detection by screening populations at risk for type 2 diabetesThomas R Einarson, Basil G Bereza, Annabel Acs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2004
Cost analysis of secondary prophylaxis with oral clodronate versus pamidronate in metastatic breast cancer patientsDorothy Romanus, Neill Iscoe, Carlo Deangelis, et al.
Paediatric Drugs|May 6, 2005
Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, CanadaMichael Iskedjian, John H Walker, Gaston De Serres, et al.
Pharmacoeconomics|December 13, 2005
Willingness to pay for inhaled insulin: a contingent valuation approachHamid Sadri, Linda D MacKeigan, Lawrence A Leiter, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 3, 2012
Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorderBasil G Bereza, Márcio Machado, Arun V Ravindran, et al.
The Annals of Pharmacotherapy|April 29, 2004
Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depressionMichiel E H Hemels, Siegfried Kasper, Evelyn Walter, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Clinical Therapeutics|February 13, 2003
An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based studyThomas R Einarson, Colleen J Metge, Michael Iskedjian, et al.
Pharmacoeconomics|October 27, 2007
The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analysesMárcio Machado, Michael Iskedjian, Inés A Ruiz, et al.
Journal of Environmental and Public Health|December 17, 2011
Objective assessment of an ionic footbath (IonCleanse): testing its ability to remove potentially toxic elements from the bodyDeborah A Kennedy, Kieran Cooley, Thomas R Einarson, et al.
The American Journal of Gastroenterology|June 4, 2009
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysisSimerpal K Gill, Lisa O'Brien, Thomas R Einarson, et al.
Current Medical Research and Opinion|November 8, 2016
Systematic literature review of the health economic implications of early detection by screening populations at risk for type 2 diabetesThomas R Einarson, Basil G Bereza, Annabel Acs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2004
Cost analysis of secondary prophylaxis with oral clodronate versus pamidronate in metastatic breast cancer patientsDorothy Romanus, Neill Iscoe, Carlo Deangelis, et al.
Paediatric Drugs|May 6, 2005
Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, CanadaMichael Iskedjian, John H Walker, Gaston De Serres, et al.
Pharmacoeconomics|December 13, 2005
Willingness to pay for inhaled insulin: a contingent valuation approachHamid Sadri, Linda D MacKeigan, Lawrence A Leiter, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 3, 2012
Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorderBasil G Bereza, Márcio Machado, Arun V Ravindran, et al.
The Annals of Pharmacotherapy|April 29, 2004
Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depressionMichiel E H Hemels, Siegfried Kasper, Evelyn Walter, et al.
Pageof 13